FEBRUARY 23, 2020
STOCKS: AAPL, ACAD, NFLX, GOOGL, NVDA, AMZN
Michael Kramer owns SPY Calls
Michael Kramer and the clients of Mott Capital own AAPL, GOOGL, ACAD, NFLX
Join me on February 27 at 12 PM ET for a FREE webinar hosted by Interactive Brokers. I will cover why I think the S&P 500 is rising to 3,600. Sign up
It will not be a busy week in-terms of economic newsflow, but we will likely see a great amount of volatility. Markets will still be trying to figure out what the potential impact of the coronavirus is on the economy. But investors will get their first taste on Friday night when China will release its official manufacturing PMI. Premium content – Could See Some Important Data At The End Of This Week
S&P 500 (SPY)
The S&P 500 created a couple of reversal patterns, with two falling wedges, and a potential double bottom. We may get a better sense of things once the futures open, and Asia starts trading. There are several levels of support in the index at 3,316, and then 3,300, with a big gap fill down around 3,260.
If the index should rise, and the reversal patterns prove to be correct, the index can increase to around 3,373.
Amazon’s cup and handle pattern vanished rather quickly after falling through support at 2,134. It likely means that the shares retest support and the prior all-time highs of roughly 2,050.
Alphabet broke support and is now likely to test support at $1,430.
Apple has been dropping, and now the RSI is trending lower, and it means that the stock is in a period of consolidation. The stock is at support at $311, and the next significant level of support comes around $308. If the uptrend breaks, we could see some further downside in the stock, potentially to the $290 region.
The RSI on NFLX continues to trend higher, and I think that means the stock continues higher, pushing towards $400.
I continue to believe that Nvidia will fall and fill the gap at $273.
Acadia will report results on Wednesday, and I’m hoping to hear something about a pre-sNDA meeting with the FDA on Dementia-related psychosis. The RSI is now trending higher, and I think this one is heading back to the highs of around $51. I think Nuplazid has a chance of getting an approval for DRP before the end of 2020; I’m keeping my fingers crossed.
Have a great Sunday
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.